about
Recent Advances in Chemotherapy and Surgery for Colorectal Liver MetastasesStrategies to prevent peritoneal carcinomatosis arising from colorectal cancer.Pancreaticoduodenectomy with mesentericoportal vein resection for adenocarcinoma of the pancreatic head.Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.Treatment of gastric peritoneal carcinomatosis by combining complete surgical resection of lesions and intraperitoneal immunotherapy using catumaxomab.Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapyComplications of Cytoreductive Surgery and HIPEC in the Treatment of Peritoneal MetastasesCytoreductive Surgery plus HIPEC for Peritoneal Metastases from Colorectal CancerThe multidisciplinary management of gastrointestinal cancer. Pancreatic cancer: from pathogenesis to cure.Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II-III colorectal cancerParenchymal-sparing hepatectomies (PSH) for bilobar colorectal liver metastases are associated with a lower morbidity and similar oncological results: a propensity score matching analysisCombined liver surgery and RFA for patients with gastroenteropancreatic endocrine tumors presenting with more than 15 metastases to the liver.Postoperative peritonitis without an underlying digestive fistula after complete cytoreductive surgery plus HIPEC.Leukocytosis and neutrophilia predict outcome in locally advanced esophageal cancer treated with definitive chemoradiation.Current status and future directions in the treatment of peritoneal dissemination from colorectal carcinoma.Definition of patients presenting a high risk of developing peritoneal carcinomatosis after curative surgery for colorectal cancer: a systematic review.Incidence and prognosis of synchronous colorectal carcinomatosis.Isolated pelvic perfusion in irradiated unresectable recurrence of pelvic tumor: preliminary outcome and ongoing study.Surgical strategy for low rectal cancers.Predictive factors of postoperative mortality after junctional and gastric adenocarcinoma resection.Role of aggressive surgery for peritoneal metastasesParenteral and enteral nutritional support (excluding immunonutrition).Abdominal surgical emergencies in patients with advanced cancer.The role of image-guided therapy in the management of colorectal cancer metastatic disease.Ninety percent of the adverse outcomes occur in 10% of patients: can we identify the populations at high risk of developing peritoneal metastases after curative surgery for colorectal cancer?Improved retroviral suicide gene transfer in colon cancer cell lines after cell synchronization with methotrexate.Single-port endoscopic mesocolic and mesorectal excision using an extraperitoneal approach.Is signet-ring cell carcinoma a specific entity among gastric cancers?Intra-arterial therapies for colorectal cancer liver metastases (radioembolization excluded).Can a Benefit be Expected from Surgical Debulking of Unresectable Pseudomyxoma Peritonei?Anal cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SNFCP).Are G3 ENETS neuroendocrine neoplasms heterogeneous?Comprehensive study of ovarian metastases in young women with peritoneal pseudomyxoma: is a preservation of fertility possible?A new policy regarding ovarian resection in young women treated for peritoneal carcinomatosis.Diffuse malignant peritoneal mesothelioma: Evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE Database: Multi-Institutional Retrospective Study.Transanal endoscopic total mesorectal excision combined with single-port laparoscopy.Sarcopenia is Associated with Chemotherapy Toxicity in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer.Variation in the peritoneal cancer index scores between surgeons and according to when they are determined (before or after cytoreductive surgery).Factors influencing recurrence following initial hepatectomy for colorectal liver metastases.Incidence and prognosis of synchronous colorectal carcinomatosis: evolution since 1985?
P50
Q28067408-998F8160-6562-4357-BE88-DBC79D2C0B12Q30239825-577B3BC1-2263-433D-9E4A-655E6428E516Q33997783-7AA9676F-4AD0-43BB-B985-6B0EE4C17243Q34013275-3D2D7C39-6458-49B8-AA4D-471E17EC8D82Q35109585-810F41CA-4BB4-41B2-96CB-800668B88980Q36356176-50ABD5A0-6C23-4CCC-979B-A10424398270Q36758917-9401F6CD-8D60-4CA4-BE53-BE913E69F998Q36758936-9B207CC5-6FC1-4C15-BC1D-1EF76E63F6EAQ37028521-D7DAE989-1B60-4D0A-A44F-5089F7C4E185Q37111136-BC74581E-4B24-4EF7-8102-25F49976D807Q37231430-87DBB876-D8FB-48C9-B6F1-093602018CF3Q37493025-B215AC5A-B2B6-44FE-92B1-4C83BD808674Q37645734-B9EFF284-F0AB-494D-9AC1-EC785ED883B5Q37706953-1B2A0033-2EF4-48D5-9767-3C46D9D0B268Q38047545-4A8C93FA-4C01-4743-9104-76653BEA0233Q38054557-49B9A521-1FF7-443D-A853-7CEE1D5FAC74Q38096412-659FCAAA-BC46-42AE-BB05-38B3B2468F6BQ38192252-48545B44-CB35-4BA5-9E45-AB19A415DB12Q38279652-CAE847EF-5144-44BB-BA2D-8F6759812032Q38453510-AD6CF928-0CCE-44F1-84CB-AB1B7E92D0C8Q38555902-F37D69B9-5A78-440C-86C3-BB30C27AC0F1Q38575466-3804174B-4720-434B-B53E-D81E6837C6C2Q38628136-4612164E-A0F9-439B-9B2C-639C04C7B0B1Q38753178-6D8CFF6A-D456-4D95-8AE8-3A5715A8C6BDQ38765795-C466237C-8350-4E66-A9A4-4D2669CF9DFCQ38792268-8A2CBE05-4FE2-42BC-B38E-AEBC10D24AC8Q38872074-7A133CA8-E28C-43AA-827A-F83F6FA858B3Q38938637-0852B56A-56DB-4CD8-80F9-7607B07A3F1DQ39043550-5D534DDB-C03A-4429-AEBC-830733619269Q39179176-EB74B139-C131-44CE-9554-11755946BEF3Q39370469-9BDA11F8-01C3-4BFB-89B8-1F72DF552D23Q39386499-F4EBE0BE-3DCA-4142-B7F4-69769B7924E0Q39446396-E78562BB-4304-444B-8D2B-47D72487665FQ39474649-91188BFE-2B64-497B-8905-7EF8EE70BEB3Q39545345-D4200FCC-820B-43F1-AF12-57441F7C0FA6Q39572497-90F8DC37-F4AB-4874-94B2-ED3B5CBE4AE2Q39648893-CD9C73CC-7F93-48F5-A274-D7409E3583FDQ39659727-2AC7DEC8-92AB-4BBD-8166-EB5770E2554EQ39680526-3126EBEC-0E04-4F4B-A061-1D6E897C3452Q39691415-04DCECED-9942-4203-8994-193F672F0D74
P50
description
chirurg
@nl
hulumtuese
@sq
researcher
@en
ricercatrice
@it
հետազոտող
@hy
name
Diane Goere
@en
Diane Goere
@es
Diane Goere
@nl
Diane Goéré
@fr
type
label
Diane Goere
@en
Diane Goere
@es
Diane Goere
@nl
Diane Goéré
@fr
altLabel
Diane Goere Charuel
@en
Diane Goéré
@en
prefLabel
Diane Goere
@en
Diane Goere
@es
Diane Goere
@nl
Diane Goéré
@fr
P214
P269
P106
P1412
P21
P213
0000 0003 5963 8220
P214
P269
P31
P496
0000-0002-1440-0086
P569
1969-01-01T00:00:00Z
P735
P7859
viaf-219328171